chr17-4446123-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182538.5(SPNS3):c.478G>A(p.Val160Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182538.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPNS3 | NM_182538.5 | c.478G>A | p.Val160Ile | missense_variant | 4/12 | ENST00000355530.7 | NP_872344.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPNS3 | ENST00000355530.7 | c.478G>A | p.Val160Ile | missense_variant | 4/12 | 2 | NM_182538.5 | ENSP00000347721.2 | ||
SPNS3 | ENST00000575194.5 | n.341G>A | non_coding_transcript_exon_variant | 3/11 | 1 | ENSP00000460781.1 | ||||
SPNS3 | ENST00000572078.1 | n.269G>A | non_coding_transcript_exon_variant | 2/4 | 3 | |||||
SPNS3 | ENST00000576069.5 | n.352G>A | non_coding_transcript_exon_variant | 3/6 | 5 | ENSP00000519557.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 250980Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135654
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461342Hom.: 0 Cov.: 30 AF XY: 0.0000165 AC XY: 12AN XY: 726962
GnomAD4 genome AF: 0.000112 AC: 17AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.478G>A (p.V160I) alteration is located in exon 4 (coding exon 4) of the SPNS3 gene. This alteration results from a G to A substitution at nucleotide position 478, causing the valine (V) at amino acid position 160 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at